S. Leone
5 Papers
S. Leone is an academic researcher. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
Chiara Agrati,Concetta Castilletti,Delia Goletti,Alessandra Sacchi,Veronica Bordoni,Davide Mariotti,Stefania Notari,Giulia Matusali,Silvia Meschi,Linda Petrone,Alessandra Aiello,Saeid Najafi Fard,Chiara Farroni,Francesca Colavita,Daniele Lapa,S. Leone,Alessandro Agresta,Maria Rosaria Capobianchi,Giuseppe Ippolito,Francesco Vaia,Vincenzo Puro,Eleonora Cimini,Eleonora Tartaglia,Rita Casetti,Germana Grassi,Flavia Cristofanelli,Andrea Capri,Annapaola Santoro,Nicoletta Orchi,Aurora Bettini,Massimo Francalancia,Eliana Specchiarello +31 more
TL;DR: The long lasting cell-mediated immune response after 3 months from vaccination highlight its importance in the maintaining of specific immunity able to expand again to fight eventual new antigen encountering.
35
The possible effect of socio-behavioral factors and public health actions on the mpox epidemic slowdown
Francesco Vairo,S. Leone,V Mazzotta,Pierluca Piselli,Gabriella De Carli,Simone Lanini,F. Maggi,Emanuele Nicastri,Roberta Gagliardini,S. De Vita,Andrea Siddu,Giovanni Rezza,Alessandra Barca,Francesco Vaia,Andrea Antinori,Enrico Girardi +15 more
TL;DR: In this paper , the authors explore the possible factors affecting the trend of mpox cases in an Italian region (Lazio) with a rapid roll-out of the vaccination campaign.
21
GRAd-COV2 vaccine provides potent and durable immunity in a randomised placebo-controlled phase 2 trial (COVITAR)
Stefania Capone,Francesco Maria Fusco,Stefano Milleri,Silvio Borrè,Sergio Carbonara,Sergio Lo Caputo,S. Leone,Giada Gori,Paolo Maggi,Antonio Cascio,Miriam Lichtner,Roberto Cauda,S. Dal Zoppo,Maria Vittoria Cossu,Ala V Gori,Silvia Roda,Paola Confalonieri,Stefano Bonora,Gabriele Missale,Mauro Codeluppi,Ivano Mezzaroma,S. Capici,Emanuele Pontali,Marco Libanore,A Diani,Simone Lanini,Simone Battella,Alessandra Maria Contino,Eva Piano Mortari,Francesca Genova,Gianluca Parente,Roger Dragonetti,Stefano Colloca,L. Visani,C. Iannacone,Rita Carsetti,Antonella Folgori,Roberto Camerini,The EpiCov study group +38 more
TL;DR: GR adenovirus-based COVID-19 vaccine was safe, and induced robust immune responses after a single immunization; the second administration increased humoral but not cellular immune responses.
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study
Paolo Corradini,Diana Giannarelli,Vincenzo Marasco,Veronica Bordoni,Maria Teresa Lupo-Stanghellini,Silvia Damian,Nicola Silvestris,Giulia Piaggio,Gennaro Ciliberto,Franco Locatelli,Valentina Sinno,Massimo Costantini,Giovanni Apolone,Alberto Mantovani,Chiara Agrati,Fabio Ciceri,Francesco Locatelli,Fausto Baldanti,Aldo Morrone,Angelo Paradiso,Carlo Salvarani,Fabrizio Tagliavini,Antonio Uccelli,Pier Luigi Zinzani,Renato Mantegazza,M. Rescigno,Daniela Fenoglio,Roberta Mortarini,Cristina Tresoldi,Laura Monteiro de Castro Conti,Chiara Mandoj,Michela Lizier,Stefania Croci,Vito Michele Garrisi,Fulvio Baggi,Tiziana Lazzarotto,Francesca Bonifazi,Fulvia Pimpinelli,Concetta Quintarelli,Rita Carsetti,Enrico Girardi,Aurora Bettini,Concetta Castilletti,Eleonora Cimini,Rita Casetti,Francesca Colavita,Flavia Cristofanelli,Massimo Francalancia,S. Gili,Delia Goletti,Giulia Gramigna,Germana Grassi,Daniele Lapa,S. Leone,Davide Mariotti,Giulia Matusali,Silvia Meschi,Stefania Notari,Enzo Puro,Marika Rubino,Alessandra Sacchi,Eleonora Tartaglia,Filippo de Braud,Maria Teresa Lupo Stanghellini,Lorenzo Dagna,Francesca Ogliari,M. Filippi,A. Bruno,Gloria Catalano,Rosamaria Nitti,Andrea Mengarelli,Francesco Marchesi,Giancarlo Paoletti e Gabriele Minuti,Elena Papa,Elena Azzolini,Luca Germagnoli,Carlo Selmi,Maria De Santis,Carmelo Carlo-Stella,Alexia Bertuzzi,Francesca Motta,Angela Ceribelli,Chiara Miggiano,Giulia Fornasa,Sara Monti,Carlomaurizio Montecucco,Dario Graceffa,Maria Grazia Catanoso,Monica Guberti,Carmine Pinto,Francesco Merli,Franco Valzania,Rosa Divella,Antonio Tufaro,Sabina Delcuratolo,Mariana Miano,Paolo Pronzato,Matilde Inglese,Carlo Genova,Caterina Lapucci,Alice Laroni,Ilaria Poirè,Marco Fusconi,Vittorio Stefoni,Maria Abbondanza Pantaleo,Serena Di Cosimo,Elena Turola,I. Pulice,Stefania Trinca,Chiara Pozzi,Irene Cassaniti,Alessandro Barberini,Arianna Belvedere,Rinaldi Elena,Federica Bortone,Maria Giovanna Dal Bello,Silvia Corazza +116 more
TL;DR: Investigating the immunogenicity of the primary vaccination schedule and booster dose in patients with solid tumors, hematological malignancies, neurological disorders, and immunorheumatological diseases concluded that the booster dose can improve both humoral and T-cell responses.
Prevention from Sharp Injuries in the Hospital Sector: An Italian National Observatory on the Implementation of the Council Directive 2010/32/EU before and during the COVID-19 Pandemic
Gabriella De Carli,Alessandro Agresta,Maria Giuseppina Lecce,P. Marchegiano,G Micheloni,Dimitri Sossai,Giuseppe Campo,P. Tomao,Nicoletta Vonesch,S. Leone,Vincenzo Puro +10 more
TL;DR: Safety measures were implemented in Italian hospitals, and although the average injuries per hospital did not show a decrease, these measures could have helped protect healthcare workers during the COVID-19 pandemic, mitigating its potential impact on the increase in situations at risk of injury.